|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-12-5
|
|
pubmed:abstractText |
To examine the effects of the antimuscarinic agent solifenacin on urinary urgency, using a range of novel and established outcome measures, as urgency is the principal symptom of the overactive bladder syndrome (OAB).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1120-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18990175-Dose-Response Relationship, Drug,
pubmed-meshheading:18990175-Double-Blind Method,
pubmed-meshheading:18990175-Female,
pubmed-meshheading:18990175-Humans,
pubmed-meshheading:18990175-Male,
pubmed-meshheading:18990175-Middle Aged,
pubmed-meshheading:18990175-Muscarinic Antagonists,
pubmed-meshheading:18990175-Quinuclidines,
pubmed-meshheading:18990175-Severity of Illness Index,
pubmed-meshheading:18990175-Tetrahydroisoquinolines,
pubmed-meshheading:18990175-Treatment Outcome,
pubmed-meshheading:18990175-Urinary Bladder, Overactive,
pubmed-meshheading:18990175-Urination Disorders,
pubmed-meshheading:18990175-Urodynamics
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
|
|
pubmed:affiliation |
King's College Hospital, Department of Urogynaecology, London, UK. lcardozo@compuserve.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
